HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

John A. Conti, MD

Board Certifications: Hospice Medicine, Internal Medicine, Medical Oncology and Palliative care

Specializations: Hematology and Medical Oncology

Languages: English and Spanish

Locations: Belleville, NJ, Montclair, NJ and Roselle, NJ

Dr. Conti has been practicing in New Jersey for nearly 25 years. Known for his innovative work at Memorial Sloan-Kettering Cancer Center, his research in the field of colon cancer treatment has become the standard of care throughout the country. He has established an exceptional network of connections to treat challenging cases including rare diagnoses, atypical presentations of common cancers and unique patient challenges. Dr. Conti is the medical director at Atlantic Hospice and Medical Director of the cancer program at Hackensack Meridian Health Mountainside Medical Center, helping to ensure that hospital-based patient care meets the same uncompromising standards that he provides through his office-based practice.

Education

Medical Education

  • University of Medicine and Dentistry of New Jersey

RESIDENCY

  • University of Medicine and Dentistry of New Jersey

FELLOWSHIPS

  • Memorial Sloan-Kettering Cancer Center, N.Y.

FELLOW

  • American College of Physicians

OBSERVERSHIP

Awards and honors

awards and honors

PROFESSIONAL MEMBERSHIPS

  • American Society of Clinical Oncology
  • American Association of Cancer Researchers
  • New Jersey Oncology Society

HOSPITAL AFFILIATIONS

Medical Director Atlantic Hospice, Medical Director of the cancer program at Hackensack Meridian Health Mountainside Medical Center

we are here for you

For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.